Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1

Journal of Biological Chemistry

Volumn 288, Issue 16, 2013, Pages 11155-11164

  Zhao, Baoyu ^a,b,c   Yuan, Cai ^a,c   Li, Rui ^a,b,c   Qu, Dan ^c,d   Huang, Mingdong ^a,c   Ngo, Jacky Chi Ki ^a,d  

^a FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Danish Chinese Centre for Proteases and Cancer   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

FUTURE DESIGNS; HEPATOCYTE GROWTH FACTOR; MATRIPTASE; MOLECULAR INHIBITORS; SERINE PROTEASE; STRUCTURAL BASIS; STRUCTURAL INSIGHTS;

BIOCHEMISTRY; BIOLOGY;

AMINO ACIDS;

APROTININ; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; MATRIPTASE; SCATTER FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS;

CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE ENDOPEPTIDASES;

EID: 84876516737     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.454611     Document Type: Article

References (43)

1. Lin, C. Y., Anders, J., Johnson, M., Sang, Q. A., and Dickson, R. B. (1999) Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem. 274, 18231-18236.
2. Takeuchi, T., Shuman, M. A., and Craik, C. S. (1999) Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc. Natl. Acad. Sci. U.S.A. 96, 11054-11061.
3. Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R., and Craik, C. S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342.
4. Hooper, J. D., Clements, J. A., Quigley, J. P., and Antalis, T. M. (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276, 857-860.
5. Oberst, M. D., Singh, B., Ozdemirli, M., Dickson, R. B., Johnson, M. D., and Lin, C. Y. (2003) Characterization of Matriptase Expression in Normal Human Tissues. J. Histochem. Cytochem. 51, 1017-1025.
6. Kilpatrick, L. M., Harris, R. L., Owen, K. A., Bass, R., Ghorayeb, C., Bar-Or, A., and Ellis, V. (2006) Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 108, 2616-2623.
7. Cheng, M. F., Jin, J. S., Wu, H. W., Chiang, P. C., Sheu, L. F., and Lee, H. S. (2007) Matriptase expression in the normal and neoplastic mast cells. Eur. J. Dermatol. 17, 375-380.
8. List, K., Haudenschild, C. C., Szabo, R., Chen, W., Wahl, S. M., Swaim, W., Engelholm, L. H., Behrendt, N., and Bugge, T. H. (2002) Matriptase/MTSP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21, 3765-3779.
9. Lee, S. L., Dickson, R. B., and Lin, C. Y. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725.
10. Kang, J. Y., Dolled-Filhart, M., Ocal, I. T., Singh, B., Lin, C. Y., Dickson, R. B., Rimm, D. L., and Camp, R. L. (2003) Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 63, 1101-1105.
11. Tsai, W. C., Chu, C. H., Yu, C. P., Sheu, L. F., Chen, A., Chiang, H., and Jin, J. S. (2008) Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis. Markers 24, 89-99.
12. Santin, A. D., Cane', S., Bellone, S., Bignotti, E., Palmieri, M., De Las Casas, L. E., Anfossi, S., Roman, J. J., O'Brien, T., and Pecorelli, S. (2003) The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma. Cancer 98, 1898-1904.
13. Lee, J. W., Yong Song, S., Choi, J. J., Lee, S. J., Kim, B. G., Park, C. S., Lee, J. H., Lin, C. Y., Dickson, R. B., and Bae, D. S. (2005) Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum. Pathol. 36, 626-633.
14. Oberst, M. D., Johnson, M. D., Dickson, R. B., Lin, C. Y., Singh, B., Stewart, M., Williams, A., al-Nafussi, A., Smyth, J. F., Gabra, H., and Sellar, G. C. (2002) Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters. Clin. Cancer Res. 8, 1101-1107.
15. Tanimoto, H., Shigemasa, K., Tian, X., Gu, L., Beard, J. B., Sawasaki, T., and O'Brien, T. J. (2005) Transmembrane serine protease TADG-15 (ST14/ Matriptase/MT-SP1): expression and prognostic value in ovarian cancer. Br. J. Cancer 92, 278-283.
16. Saleem, M., Adhami, V. M., Zhong, W., Longley, B. J., Lin, C. Y., Dickson, R. B., Reagan-Shaw, S., Jarrard, D. F., and Mukhtar, H. (2006) A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol. Biomarkers Prev. 15, 217-227.
17. Cheng, M. F., Tzao, C., Tsai, W. C., Lee, W. H., Chen, A., Chiang, H., Sheu, L. F., and Jin, J. S. (2006) Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis. Esophagus 19, 482-486.
18. Tsai, W. C., Chao, Y. C., Lee, W. H., Chen, A., Sheu, L. F., and Jin, J. S. (2006) Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology 49, 388-395.
19. List, K. (2009) Matriptase: a culprit in cancer? Future Oncol. 5, 97-104.
20. Oberst, M. D., Williams, C. A., Dickson, R. B., Johnson, M. D., and Lin, C. Y. (2003) The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278, 26773-26779.
21. Oberst, M. D., Chen, L. Y., Kiyomiya, K., Williams, C. A., Lee, M. S., Johnson, M. D., Dickson, R. B., and Lin, C. Y. (2005) HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am. J. Physiol. Cell Physiol. 289, C462-470.
22. Lee, M. S., Tseng, I. C., Wang, Y., Kiyomiya, K., Johnson, M. D., Dickson, R. B., and Lin, C. Y. (2007) Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am. J. Physiol. Cell Physiol. 293, C95-105.
23. Tseng, I. C., Xu, H., Chou, F. P., Li, G., Vazzano, A. P., Kao, J. P., Johnson, M. D., and Lin, C. Y. (2010) Matriptase activation, an early cellular response to acidosis. J. Biol. Chem. 285, 3261-3270.
24. Shimomura, T., Denda, K., Kitamura, A., Kawaguchi, T., Kito, M., Kondo, J., Kagaya, S., Qin, L., Takata, H., Miyazawa, K., and Kitamura, N. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272, 6370-6376.
25. Kawaguchi, T., Qin, L., Shimomura, T., Kondo, J., Matsumoto, K., Denda, K., and Kitamura, N. (1997) Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272, 27558-27564.
26. Kataoka, H., Suganuma, T., Shimomura, T., Itoh, H., Kitamura, N., Nabeshima, K., and Koono, M. (1999) Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47, 673-682.
27. Shimomura, T., Denda, K., Kawaguchi, T., Matsumoto, K., Miyazawa, K., and Kitamura, N. (1999) Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type I from a transmembrane form. J. Biochem. 126, 821-828.
28. Tsuzuki, S., Murai, N., Miyake, Y., Inouye, K., Hirayasu, H., Iwanaga, T., and Fushiki, T. (2005) Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem. J. 388, 679-687.
29. Lin, C. Y., Anders, J., Johnson, M., and Dickson, R. B. (1999) Purification and characterization of a complex containing matriptase and a Kunitztype serine protease inhibitor from human milk. J. Biol. Chem. 274, 18237-18242.
30. Benaud, C. M., Oberst, M., Dickson, R. B., and Lin, C. Y. (2002) Deregulated activation of matriptase in breast cancer cells. Clin. Exp. Metastasis 19, 639-649.
31. Denda, K., Shimomura, T., Kawaguchi, T., Miyazawa, K., and Kitamura, N. (2002) Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J. Biol. Chem. 277, 14053-14059.
32. Shia, S., Stamos, J., Kirchhofer, D., Fan, B., Wu, J., Corpuz, R. T., Santell, L., Lazarus, R. A., and Eigenbrot, C. (2005) Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. J. Mol. Biol. 346, 1335-1349.
33. Kojima, K., Tsuzuki, S., Fushiki, T., and Inouye, K. (2008) Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J. Biol. Chem. 283, 2478-2487.
34. Friedrich, R., Fuentes-Prior, P., Ong, E., Coombs, G., Hunter, M., Oehler, R., Pierson, D., Gonzalez, R., Huber, R., Bode, W., and Madison, E. L. (2002) Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase. J. Biol. Chem. 277, 2160-2168.
35. Yuan, C., Chen, L., Meehan, E. J., Daly, N., Craik, D. J., Huang, M., and Ngo, J. C. (2011) Structure of catalytic domain of Matriptase in complex with Sunflower trypsin inhibitor-1. BMC Struct. Biol. 11, 30.
36. Collaborative Computational Project, Number 4 (1994) The CCP4 suite; Programs for protein crystallography. Acta Crystallogr.DBiol. Crystallogr. 50, 760-763.
37. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255.
38. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132.
39. Jin, L., Pandey, P., Babine, R. E., Weaver, D. T., Abdel-Meguid, S. S., and Strickler, J. E. (2005) Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: an essential step for the iterative structure-based design of factor XI inhibitors. Acta Crystallogr. D Biol. Crystallogr. 61, 1418-1425.
40. Kirchhofer, D., Peek, M., Li, W., Stamos, J., Eigenbrot, C., Kadkhodayan, S., Elliott, J. M., Corpuz, R. T., Lazarus, R. A., and Moran, P. (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J. Biol. Chem. 278, 36341-36349.
41. van de Locht, A., Bode, W., Huber, R., Le Bonniec, B. F., Stone, S. R., Esmon, C. T., and Stubbs, M. T. (1997) The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. EMBO J. 16, 2977-2984.
42. Guex, N., and Peitsch, M. C. (1997) SWISS-MODEL and the Swiss-Pdb-Viewer: An environment for comparative protein modeling. Electrophoresis 18, 2714-2723.
43. Salameh, M. A., Soares, A. S., Navaneetham, D., Sinha, D., Walsh, P. N., and Radisky, E. S. (2010) Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin. J. Biol. Chem. 285, 36884-36896.